Condition 1: Acute kidney injury. Condition 2: Remote ischemic preconditioning. Condition 3: Coronary artery bypass graft surgery.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: • Candidate cardiac surgical patients • Elective or urgent on pump coronary artery bypass grafting (CABG) • Age 18 to 85 years • Signed informed consent Exclusion Criteria: • End-stage renal disease (receiving hemodialysis or glomerular filtration rate <15 ml/min/1.73m2) • Peripheral vascular disease • Severe hepatic disease • Planned off-pump surgery • Pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of postoperative acute kidney injury (AKI). Timepoint: Within the first 72 hours after surgery. Method of measurement: Defined as an elevation of serum creatinine of =0.3 mg/dl or =50% within 72 hours after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospital stay. Timepoint: Through hospital stay after surgery. Method of measurement: in days.;Duration of ICU stay. Timepoint: Through ICU stay. Method of measurement: in days.;All cause mortality. Timepoint: Through hospital stay after surgery. Method of measurement: number of observed cases.;Requiring hemodialysis. Timepoint: Through hospital stay after surgery. Method of measurement: number of observed cases.;Postoperative liver function. Timepoint: Preoperatively and at 24 h post-surgery. Method of measurement: By measuring serum AST, ALT, T.bilirubin, and albumin.;Incidence of postoperative atrial fibrillation (AF). Timepoint: Within the first 72 hours after surgery. Method of measurement: Defined as the incidence of new-onset AF lasting for five minutes or longer.;Incidence of postoperative stroke. Timepoint: Through hospital stay after surgery. Method of measurement: Defined as a new ischemic or hemorrhagic cerebrovascular accident with neurological deficit lasting >24 h. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz nephro-urology research center